Merck/Intervet/Schering-Plough Animal Health is a global, research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services. We offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck.
Merck's animal health division, formerly known as Intervet/Schering-Plough Animal Health, announced that it has adopted the name of its parent company and will now be called Merck Animal Health.
It is the world leader in pharmaceuticals and vaccines for aquaculture and major products in its portfolio are the antibiotic AQUAFLOR (florfenicol), the parasiticide SLICE (emamectin benzoate) and the vaccine ranges AQUAVAC and NORVAX. The company is based in Boxmeer, The Netherlands.
We are a highly proactive, robust and diversified company with a strong, scientifically-proven, product portfolio and an ever-growing global reach.
With offices in more than 50 countries, we successfully market our products in over 140 countries and operate a network of manufacturing sites and research and development (R&D) facilities around the world.
Record-Breaking Year for Norwegian Cold-Water Prawns Norway
Shift Toward High-Value Consumer Products Drives Revenue to New Heights Despite Lower Catch Volumes
Norway has solidified its position as a global leader in the shellfish industry, exporting 31,8...
EU Tightens Safety Standards for Frozen Tuna Imports Starting 2026 European Union
The European Union is moving to eliminate "trade fraud" and bolster food safety in the seafood sector by implementing stricter freezing requirements for tuna.
Under the newly issued Delegated Reg...
Copyright 1995 - 2026 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER